Clinical trial
Determination of Blood Tumor Cells Using Magnetic Nanoparticles
NCT04290923 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determination of Blood Tumor Cells Using Magnetic Nanoparticles
- Lead sponsor
- University of Zurich
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2017
- Completion date
- December 30, 2022
- Enrollment
- 71 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
abnormalities cell epithelial, leukemia, lymphocytic, chronic, b-cell